Douillard, Jean-Yves <br/><br/>
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Feb 2010 
 - 220-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e3181c814e7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Cisplatin--therapeutic use<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Meta-Analysis as Topic<br/>Neoplasm Staging<br/>Proportional Hazards Models<br/>Randomized Controlled Trials as Topic<br/>Survival Rate<br/>Treatment Outcome<br/>Vinblastine--analogs & derivatives<br/>Vinorelbine